Joao Monteiro, Chief Editor at Nature Medicine, shared an article by Norah L. Crossnohere et al. published in Nature Medicine on LinkedIn:
”Asking patients about their symptoms, functioning and well-being during clinical trials can influence trial outcomes, regulatory decisions and clinical practice.
In a new opinion article, Norah L Crossnohere and colleagues highlight several cases when PRO endpoints in clinical trials have provided valuable insights into the benefits and burdens of interventions beyond those obtained by physiological, laboratory, clinician-reported, observer-reported or performance outcomes alone.
Read it now in Nature Medicine.”
Title: Patient-reported outcome measures add value as clinical trial endpoints
Authors: Norah L. Crossnohere, Anne L. R. Schuster, Jeffrey Bruckel, Ronald C. Chen, Amy M. Cizik, Samantha Cruz Rivera, Christopher Muth, Linda Nelsen, Derek Kyte, Albert W. Wu, Elissa Thorner, Claire Snyder, Michael Brundage
More posts featuring Joao Monteiro.